Related Experiment Video

Updated: Nov 9, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.9K

Molecular Profiling Associated with Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2)-Mediated

Mohd Altaf Najar1, Prashant Kumar Modi1, Poornima Ramesh1

  • 1Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore 575018, India.

Journal of Proteome Research
|April 12, 2021
PubMed

Insights

Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) drives gastric cancer progression. Inhibiting CAMKK2 halts cancer cell growth and invasion, revealing it as a promising therapeutic target for gastric adenocarcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gastric cancer is a leading cause of cancer death globally.
  • Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) is highly expressed in gastric cancer and promotes its progression.
  • Understanding CAMKK2's molecular networks is crucial for developing targeted therapies.

Purpose of the Study:

  • To identify the molecular networks regulated by CAMKK2 in gastric adenocarcinoma.
  • To investigate the therapeutic potential of inhibiting CAMKK2 in gastric cancer.
  • To elucidate the downstream effects of CAMKK2 inhibition on cellular processes.

Main Methods:

  • Treatment of gastric cancer cell lines with the CAMKK2 inhibitor STO-609.
  • Analysis of cell migration, invasion, colony formation, and cell cycle.
  • Tandem mass tag (TMT)-based quantitative proteomic analysis.
  • Validation using immunoblotting and immunofluorescence.

Main Results:

  • STO-609 treatment decreased gastric cancer cell migration, invasion, and colony formation, inducing G1/S-phase arrest.
  • Proteomic analysis identified significant changes in protein expression upon CAMKK2 inhibition.
  • Key downregulated proteins involved in cell division, DNA replication, and mesenchymal markers were identified.

Conclusions:

  • CAMKK2 plays a significant role in gastric cancer progression.
  • Inhibition of CAMKK2 effectively suppresses cancer cell proliferation and invasion.
  • CAMKK2 represents a novel and promising therapeutic target for gastric cancer treatment.
Keywords:
CAMKK2STO-609gastric cancermass spectrometry

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.8K
Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.6K

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K